Clinical Trial

Imaging Studies in Corticobasal Syndrome

Study acronym: I-CAN
Recruiting
View on ClinicalTrials.gov →
Summary
The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. The investigator's will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-05-23; most recent amendment 2026-07-13.
Trial Details
NCT Number NCT07000851
Lead Sponsor Jennifer Whitwell
Collaborators: National Institute on Aging (NIA)
Conditions Cortico Basal Degeneration, Corticobasal Syndrome, Corticobasal Syndrome(CBS), Corticobasal Degeneration, Corticobasal Degeneration (CBD), Corticobasal Syndrome (CBS)
Enrollment 80 participants
Start Date 2025-06-25
Primary Completion 2030-03-30 (estimated)
Study Completion 2031-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-14